Fundació Salut Empordà

Recent papers from Fundació Salut Empordà

1. Cross-cultural adaptation and psychometric validation of the Multiple Sclerosis Health Literacy Questionnaire (MSHLQ): a patient-reported measure for a Spanish populationInternational Journal of Health Promotion and Education · 2026
2. Epidemiological trends of invasive Streptococcus pyogenes infections in Catalonia, 2022–2024: a two-year analysisInfection · 2026
3. Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing–Remitting Multiple SclerosisInternational Journal of Molecular Sciences · 2026
4. Workplace difficulties in early-stage relapsing-remitting multiple sclerosis with low physical disabilityMultiple Sclerosis Journal - Experimental Translational and Clinical · 2026
5. Stroke Code Missed Activations by Emergency Medical Services: Identifying Gaps and Opportunities for ImprovementPrehospital Emergency Care · 2025
6. Prognostic Stratification of Familial Hypercholesterolemia Patients Using AI Algorithms: A Gender-Specific ApproachEuropean Heart Journal - Digital Health · 2025
7. [Translated article] Wood's Light in Inflammatory and Autoimmune Dermatoses, Infections and Skin CancerActas Dermo-Sifiliográficas · 2024
8. Prognostic Stratification of Familial Hypercholesterolemia Patients Using AI Algorithms: A Gender-Specific Approach2024
9. Perceived illness-related uncertainty among patients with mid-stage relapsing-remitting multiple sclerosisMultiple Sclerosis and Related Disorders · 2024
10. Sex differences in dementia diagnosis: a fourteen-year retrospective analysis of cases using the Registry of Dementia of GironaJournal of Women & Aging · 2024
11. Air pollution and children’s mental health in rural areas: compositional spatio-temporal modelScientific Reports · 2024
12. Has cross-level clinical coordination changed in the context of the pandemic? The case of the Catalan health systemBMC Health Services Research · 2024
13. Solid Facial EdemaJAMA Dermatology · 2024
14. [Translated article] Risk of Skin Cancer Associated with Disease-Modifying Therapies in Multiple Sclerosis: A Comprehensive Evidence ReviewActas Dermo-Sifiliográficas · 2024
15. Decisional Conflict Regarding Disease-Modifying Treatment Choices Among Patients with Mid-Stage Relapsing-Remitting Multiple SclerosisPatient Preference and Adherence · 2024
16. [Translated article] Vitamin D and Skin Cancer: A Controversial Society. Literature Update and ReviewActas Dermo-Sifiliográficas · 2024
17. Sex-Related Differences in Post-Stroke Anxiety, Depression and Quality of Life in a Cohort of SmokersBrain Sciences · 2024
18. Therapeutic Decision-making from the Perspective of Patients with Relapsing-remitting Multiple Sclerosis (P2-6.008)Neurology · 2024
19. Role Preferences in Treatment Decisions Among Patients with Relapsing-remitting Multiple Sclerosis (P1-6.001)Neurology · 2024
20. Vitamina D y cáncer cutáneo: una asociación controvertida. Actualización y revisión de la literaturaActas Dermo-Sifiliográficas · 2024